EyeGate Pharma is a privately held, venture back specialty pharma company focusing on applying its proprietary iontophoretic technology to safely and non-invasively deliver therapeutics to the anterior and posterior chambers of the eye to treat disease of the eye such as Uveitis and Macular Edema.